SALT LAKE CITY–(BUSINESS WIRE)–BetterRX, the leader in real-time hospice pharmacy technology, is proud to announce the appointment of Marcus Wilson, R.Ph., as itsSALT LAKE CITY–(BUSINESS WIRE)–BetterRX, the leader in real-time hospice pharmacy technology, is proud to announce the appointment of Marcus Wilson, R.Ph., as its

BetterRX Welcomes Marcus Wilson as First Chief Pharmacy Officer

2025/12/16 22:31
3 min read
For feedback or concerns regarding this content, please contact us at [email protected]

SALT LAKE CITY–(BUSINESS WIRE)–BetterRX, the leader in real-time hospice pharmacy technology, is proud to announce the appointment of Marcus Wilson, R.Ph., as its first Chief Pharmacy Officer. This strategic addition marks a major milestone in the company’s mission to eliminate medication delays and improve care at end of life.

Mr. Wilson brings more than 25 years of experience building and scaling pharmacy operations across hospice, long-term care, specialty, and medical-at-home settings. He has led multiple organizations through significant growth, including Integrity Pharmacy and Bayada Pharmacy, each scaling to multi-state operations before being acquired by private equity firms.

Most recently, Mr. Wilson has served as a trusted advisor to more than 300 pharmacies nationwide, with a focus on automation, workflow efficiency, compliance, and technology strategy. He is known for building smarter systems of care that align pharmacy operations with real-world clinical needs.

“Marcus is a respected pharmacy leader who brings deep expertise and a heart for hospice care,” said Tim Tannert, R.Ph., CEO of BetterRX. “His leadership is critical to advancing our mission and helping us reach even more patients with fast, reliable, and compassionate medication access.”

As Chief Pharmacy Officer, Mr. Wilson will oversee all pharmacy services, clinical operations, and medication strategy. He will lead the implementation of clinical pharmacy standards and operational excellence, ensure regulatory compliance, and guide the continued growth of BetterRX’s hospice-ready pharmacy network.

Mr. Wilson joins a leadership team of fellow pharmacists, including founder Jared Stong, PharmD, and CEO Tim Tannert, R.Ph. He will also lead BetterRX’s growing team of hospice-trained and experienced PharmDs who support care teams every day.

His arrival comes at a time of strong momentum for the company. In 2025, BetterRX was named to the Inc. 5000 list, and recent independent research confirms BetterRX as a mission-critical partner for hospice providers. Customers report an average of 5 to 6 hours of time savings per nurse, each week, along with improved visibility into cost and care decisions. In fact, 86 percent of BetterRX customers report a reduction in pharmacy-related service failures — a direct step toward the company’s goal of ending needless suffering caused by medication delays.

“I have always been driven by the idea of building smarter systems of care,” said Mr. Wilson. “BetterRX is solving the right problem for the right reasons. I am honored to join a team that is modernizing hospice pharmacy with urgency, compassion, and excellence.”

To learn more about BetterRX and its mission to modernize hospice pharmacy, visit www.BetterRX.com.

Contacts

James Jarman

VP of Marketing

[email protected]
385-252-9033

Market Opportunity
Manchester City Fan Logo
Manchester City Fan Price(CITY)
$0.5167
$0.5167$0.5167
+0.68%
USD
Manchester City Fan (CITY) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

SEC Backs Nasdaq, CBOE, NYSE Push to Simplify Crypto ETF Rules

SEC Backs Nasdaq, CBOE, NYSE Push to Simplify Crypto ETF Rules

The US SEC on Wednesday approved new listing rules for major exchanges, paving the way for a surge of crypto spot exchange-traded funds. On Wednesday, the regulator voted to let Nasdaq, Cboe BZX and NYSE Arca adopt generic listing standards for commodity-based trust shares. The decision clears the final hurdle for asset managers seeking to launch spot ETFs tied to cryptocurrencies beyond Bitcoin and Ether. In July, the SEC outlined how exchanges could bring new products to market under the framework. Asset managers and exchanges must now meet specific criteria, but will no longer need to undergo drawn-out case-by-case reviews. Solana And XRP Funds Seen to Be First In Line Under the new system, the time from filing to launch can shrink to as little as 75 days, compared with up to 240 days or more under the old rules. “This is the crypto ETP framework we’ve been waiting for,” Bloomberg research analyst James Seyffart said on X, predicting a wave of new products in the coming months. The first filings likely to benefit are those tracking Solana and XRP, both of which have sat in limbo for more than a year. SEC Chair Paul Atkins said the approval reflects a commitment to reduce barriers and foster innovation while maintaining investor protections. The move comes under the administration of President Donald Trump, which has signaled strong support for digital assets after years of hesitation during the Biden era. New Standards Replace Lengthy Reviews And Repeated Denials Until now, the commission reviewed each application separately, requiring one filing from the exchange and another from the asset manager. This dual process often dragged on for months and led to repeated denials. Even Bitcoin spot ETFs, finally approved in Jan. 2024, arrived only after years of resistance and a legal battle with Grayscale. According to Bloomberg ETF analyst Eric Balchunas, the streamlined rules could apply to any cryptocurrency with at least six months of futures trading on the Coinbase Derivatives Exchange. That means more than a dozen tokens may now qualify for listing, potentially unleashing a new wave of altcoin ETFs. SEC Clears Grayscale Large Cap Fund Tracking CoinDesk 5 Index The SEC also approved the Grayscale Digital Large Cap Fund, which tracks the CoinDesk 5 Index, including Bitcoin, Ether, XRP, Solana and Cardano. Alongside this, it cleared the launch of options linked to the Cboe Bitcoin US ETF Index and its mini contract, broadening the set of crypto-linked derivatives on regulated US markets. Analysts say the shift shows how far US policy has moved. Where once regulators resisted digital assets, the latest changes show a growing willingness to bring them into the mainstream financial system under established safeguards
Share
CryptoNews2025/09/18 12:40
How a 35-Year-Old Crypto Bro Help Pakistan Win Trump World

How a 35-Year-Old Crypto Bro Help Pakistan Win Trump World

The post How a 35-Year-Old Crypto Bro Help Pakistan Win Trump World appeared on BitcoinEthereumNews.com. Bloomberg said Bilal Bin Saqib helped Pakistan build ties
Share
BitcoinEthereumNews2026/03/31 08:55
Key Reason Why Strategy Didn’t Buy Any Bitcoin (BTC)

Key Reason Why Strategy Didn’t Buy Any Bitcoin (BTC)

The post Key Reason Why Strategy Didn’t Buy Any Bitcoin (BTC) appeared on BitcoinEthereumNews.com. Strategy, the largest corporate holder of Bitcoin, has uncharacteristically
Share
BitcoinEthereumNews2026/03/31 08:45